Evidence map›Paper›PMID 28369776›Full record

Trial reportBritish journal of haematology2018

Clonal haematopoiesis is not prevalent in survivors of childhood cancer.

Grace Collord, Naomi Park, Marina Podestà, Monica Dagnino, Daniela Cilloni, David Jones, Ignacio Varela, Francesco Frassoni, George S Vassiliou

Open access · hybridAbstract readClinical TrialLetter
In one paragraph

Trial report in British journal of haematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Clonal Hematopoiesis in Women With Breast Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Haematologica · 2019
    Article
  13. Premature Physiologic Aging as a Paradigm for Understanding Increased Risk of Adverse Health Across the Lifespan of Survivors of Childhood Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Grace CollordWellcome Trust Sanger Institute, Cambridge, UK.
Naomi ParkWellcome Trust Sanger Institute, Cambridge, UK.
Marina PodestàLaboratorio Cellule Staminali e Terapie Cellulari, Istituto Giannina Gaslini IRCCS, Genova, Italy.
Monica DagninoLaboratorio Cellule Staminali e Terapie Cellulari, Istituto Giannina Gaslini IRCCS, Genova, Italy.
Daniela CilloniDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
David JonesWellcome Trust Sanger Institute, Cambridge, UK.
Ignacio VarelaInstituto de Biomedicina y Biotecnología de Cantabria, Cantabria, Spain.
Francesco FrassoniLaboratorio Cellule Staminali e Terapie Cellulari, Istituto Giannina Gaslini IRCCS, Genova, Italy.
George S VassiliouWellcome Trust Sanger Institute, Cambridge, UK.ORCID 0000-0003-4337-8022
Istituto Giannina Gaslini · ITWellcome Sanger Institute · GBCambridge University Hospitals NHS Foundation Trust · GBInstituto de Biomedicina y Biotecnología de Cantabria · ESUniversity of Cambridge · GBUniversity of Turin · IT

Funding

Cancer Research UK 23015Medical Research Council MC_PC_12009Wellcome TrustWellcome Trust WT095663MAWellcome Trust WT098051
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cancer SurvivorsHigh-Throughput Nucleotide SequencingMultiplex Polymerase Chain ReactionAdolescentAdultChildChild, PreschoolFemaleHematopoiesisHumansMaleProtein Phosphatase 2CTumor Suppressor Protein p53PPM1D protein, humanProtein Phosphatase 2CTP53 protein, humanTumor Suppressor Protein p53clonal evolutionhaematopoiesishaematopoietic stem cellslate effects of therapypaediatric cancer

Identifiers

PMID28369776
PMCPMC6001539
OpenAlexW2604768949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.